SEC Filing Details
Document Details
Form
Filing Date
May 01, 2024
Document Date
Apr 29, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Enanta Pharmaceuticals, Inc.
Issuer
ENANTA PHARMACEUTICALS INC
Filer
Kowalsky Matthew Paul
- Print Page Print Page
- Email Alerts Email Alerts
- RSS Feeds RSS Feeds
- Contact IR Contact IR